KPC-producing Enterobacter aerogenes infection
dc.contributor.author | Tuon F.F. | |
dc.contributor.author | Scharf C. | |
dc.contributor.author | Rocha J.L. | |
dc.contributor.author | Cieslinsk J. | |
dc.contributor.author | Becker G.N. | |
dc.contributor.author | Arend L.N. | |
dc.date.accessioned | 2024-03-13T00:57:14Z | |
dc.date.available | 2024-03-13T00:57:14Z | |
dc.date.issued | 2015 | |
dc.description.abstract | © 2015 Elsevier Editora Ltda.Background: Enterobacter is a common nosocomial microorganism and its carbapenem's resistance has increased. The management of these cases is unclear. Objective: We evaluated 16 patients with KPC-producing Enterobacter aerogenes infections, detailing the site of infection, therapy, clinical and epidemiological data. Methods: A retrospective and descriptive study. Clinical data were revised and KPC-2 detection was by molecular methods. Risk factors associated with mortality were compared using appropriate tests according to variable type with a significance level of 0.05. Results: The 30-day mortality rate was 37.5% with no association with inadequate treatment. Age ( p= 0.004) and Charlson score of comorbidities ( p= 0.048) were independent risk factors associated with death in the multivariate analysis. The odds ratio for age >43 years was 3.00 (95% CI: 1.02-9.32) and for Charlson score >3 was 2.00 (95% CI: 1.08-3.71). Five strains were pan-resistant based on automated susceptibility tests. All patients were treated with monotherapy. Conclusion: The clinician should be alert to carbapenem-resistant Enterobacteriaceae infection in older patients with comorbidities. The mortality is high and we believe that prompt and adequate therapy must be employed. | |
dc.description.firstpage | 324 | |
dc.description.issuenumber | 3 | |
dc.description.lastpage | 327 | |
dc.description.volume | 19 | |
dc.identifier.doi | 10.1016/j.bjid.2015.01.003 | |
dc.identifier.issn | 1678-4391 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/36200 | |
dc.relation.ispartof | Brazilian Journal of Infectious Diseases | |
dc.rights | Acesso Aberto | |
dc.subject.otherlanguage | Carbapenemase | |
dc.subject.otherlanguage | Enterobacter | |
dc.subject.otherlanguage | Infection control | |
dc.subject.otherlanguage | KPC | |
dc.title | KPC-producing Enterobacter aerogenes infection | |
dc.type | Artigo | |
local.scopus.citations | 14 | |
local.scopus.eid | 2-s2.0-84930089014 | |
local.scopus.subject | Adult | |
local.scopus.subject | Aged | |
local.scopus.subject | Aged, 80 and over | |
local.scopus.subject | Anti-Bacterial Agents | |
local.scopus.subject | beta-Lactamases | |
local.scopus.subject | Enterobacter aerogenes | |
local.scopus.subject | Enterobacteriaceae Infections | |
local.scopus.subject | Female | |
local.scopus.subject | Humans | |
local.scopus.subject | Male | |
local.scopus.subject | Microbial Sensitivity Tests | |
local.scopus.subject | Middle Aged | |
local.scopus.subject | Pregnancy | |
local.scopus.subject | Retrospective Studies | |
local.scopus.subject | Risk Factors | |
local.scopus.subject | Young Adult | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930089014&origin=inward |